An off-the-shelf, or ready to use, stem cell therapy that’s designed to replace the nerve cells lost in Parkinson’s disease and restore neurological function has been put on a developmental fast […]

Trihexyphenidyl hydrochloride is an oral therapy approved to help manage symptoms of Parkinson's disease, and often used as an add-on to levodopa treatment. The post Trihexyphenidyl hydrochloride for Parkinson’s disease appeared […]

Rytary is an approved extended-release formulation of carbidopa and levodopa that can help provide sustained symptom control for people with Parkinson's. It is taken as oral capsules, usually three to five […]

Risvodetinib, an oral therapy Abli Therapeutics is developing for people with Parkinson’s disease, reduced multiple disease-related biomarkers, the company announced. The findings come from an expanded analysis of the 201 Phase 2 study (NCT05424276), […]

Parkinson’s disease affects the muscles and brain processes involved in speaking, facial expression, and swallowing. Speech therapy for Parkinson’s can help you manage these changes, communicate more effectively, and eat and […]

Long-term exposure to ozone, a form of air pollution, may increase the risk of developing Parkinson’s disease, according to a new study from Finland. “In this nationwide register study of long-term […]